Publication details

Prolaction levels in risperidone treatment of first - episode schizophrenia

Authors

ČEŠKOVÁ Eva PŘIKRYL Radovan KAŠPÁREK Tomáš ONDRUŠOVÁ Marta

Year of publication 2004
Type Article in Periodical
Magazine / Source International Journal of Psychiatry in Clinical Practice
MU Faculty or unit

Faculty of Medicine

Citation
Field Psychiatry, sexuology
Keywords first-episode schizophrenia; risperidone; treatment response; prolactin; correlation
Description Risperidone in an average dose lower than 4 mg significantly improved both positive and negative symptoms. Co-operating responders undergoing maintanance therapy showed a mild trend towards further long-term improvement. At the end of acute treatment the average elevation of PRL levels almost doubled the baseline value. There was a trend among responders to return to their initial values during long-term therapy. Three-quarters of the subject had hyperprolactinaemia at the end of acute treatment(44 days),and after 1 year about one-quarter had hyperprolactinaemia. No significant correlation between PRL change and PANSS score change was found.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info